- Fintepla: Uses, Instructions, Side Effects, Warnings
Fintepla (fenfluramine) is used for the treatment of seizures associated with Dravet syndrome Includes Fintepla side effects, interactions and indications
- FINTEPLA® (fenfluramine) | Official Patient Website
FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
- Fenfluramine - Epilepsy Foundation
Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix
- Fintepla: Uses, Side Effects, Dosage, Interactions, and More
Learn about uses, side effects, and more of Fintepla (fenfluramine), which is a prescription oral solution that treats seizures from certain types of epilepsy
- Fintepla (fenfluramine): Uses, Side Effects, Dosage Reviews
Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions Fintepla (fenfluramine) comes as an oral solution, so it's a good option for people who can't swallow pills
- Fintepla (fenfluramine) - Uses, Side Effects, and More
Overview: Fintepla is used to treat certain types of seizures It may work by blocking certain signals that come from nerves and cause seizures Common side effects include weight loss, sleepiness
- Fintepla (FenfluramineOral Solution): Side Effects, Uses . . .
What Is Fintepla? Fintepla (fenfluramine) is an anticonvulsant used to treat seizures associated with Dravet syndrome in patients 2 years of age and older What Are Side Effects of Fintepla? Fintepla may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat, mood or behavior changes
- DailyMed - FINTEPLA- fenfluramine solution
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older
|